Literature DB >> 1004635

Inhibition of catecholamine release from the adrenal medulla by halothane. Site and mechanism of action.

M Göthert, W Dorn, I Loewenstein.   

Abstract

In isolated bovine adrenals perfused with Locke solution in a retrograde fashion we investigated the effects of halothane on the catecholamine release evoked by various secretagogues. 1. The catecholamine release induced by activation of the nicotinic receptors on the chromaffin cells with 1,1-dimethyl-4-phenylpiperazinium was almost completely inhibited (by about 90%) by 1.4 X 10(-3) M halothane. 2. It was shown by means of cumulative concentration-response curves of acetylcholine for its stimulating effect on catecholamine release (pD2 = 4.04) that halothane was a non-competitive antagonist (pD'2 = 3.17). 3. Halothane (1.4 X 10(-3) and 4.3 X 10(-3) M) did not decrease the catecholamine secretion in response to pilocarpine or histamine. 4. The 5-hydroxytryptamine-induced catecholamine release was not impaired by 1.4 X 10(-3) M halothane, but was significantly inhibited (by 44%) by 4.3 X 10(-3) M halothane. 5. At 1.4 X 10(-3) M halothane the catecholamine release induced by gamma-aminobutyric acid (GABA) was inhibited by 40%. 4.3 X 10(-3) M halothane completely blocked the secretion induced by GABA. 6. The catecholamine secretion in response to 56 mM KCl or to introduction of CaCl2 after perfusion with Locke solution deficient in CaCl2 was not reduced by halothane (1.4 X 10(-3) and 1.4 X 10(-2) M). 7. Halothane (1.4 X 10(-3) M) did not inhibit the catecholamine release evoked by acetaldehyde or tyramine from glands perfused with Ca2+ -free Locke solution throughout the experiments. It is concluded that the site of action of halothane is the cell membrane of the chromaffin cell. The anaesthetic does not impair the permeability of the membrane to calcium ions. Halothane may cause a conformational change of membrane proteins, particularly of the nicotinic receptor (and at higher concentrations of GABA and 5-hydroxytryptamine receptors); thus, stimulation may be prevented by an inhibition of agonist-receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1004635     DOI: 10.1007/bf00508391

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  The role of calcium in the secretory response of the adrenal medulla to acetylcholine.

Authors:  W W DOUGLAS; R P RUBIN
Journal:  J Physiol       Date:  1961-11       Impact factor: 5.182

2.  [The influence of calcium on catecholamine liberation].

Authors:  A PHILIPPU; H J SCHUEMANN
Journal:  Experientia       Date:  1962-03-15

3.  [A molecular basis for the action of drugs. 2. Different types of antagonists].

Authors:  A M Simonis; E J Ariëns
Journal:  Arzneimittelforschung       Date:  1966-11

4.  The effects of halothane on the responses of cardiac sympathetic ganglia to various stimulants.

Authors:  M H Alper; J H Fleisch; W Flacke
Journal:  Anesthesiology       Date:  1969-11       Impact factor: 7.892

5.  Inhibitory effect of halothane anaesthesia on catecholamine release from the adrenal medulla.

Authors:  M Göthert; C Dreyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  [On the mechanism of action of inhalation anaesthetics in the catecholamine liberation from the adrenal marrow (author's transl)].

Authors:  M Göthert; A Schmoldt; G Thielecke
Journal:  Anaesthesist       Date:  1974-03       Impact factor: 1.041

7.  Tachyphylaxis to the stimulant actions of the indirectly acting sympathomimetic amines and acetylcholine on the adrenal medulla.

Authors:  R P Rubin; S D Jaanus
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

8.  Decreased adrenal venous catecholamine concentrations during methoxyflurane anesthesia.

Authors:  T H Li; M S Shaul; B E Etsten
Journal:  Anesthesiology       Date:  1968 Nov-Dec       Impact factor: 7.892

9.  Inhibition of catecholamine secretion and calcium exchange in perfused cat adrenal glands by tetracaine and magnesium.

Authors:  R P Rubin; M B Feinstein; S D Jaanus; M Paimre
Journal:  J Pharmacol Exp Ther       Date:  1967-03       Impact factor: 4.030

10.  The effect of amethocaine on acetylcholine-induced depolarization and catecholamine secretion in the adrenal chromaffin cell.

Authors:  W W Douglas; T Kanno
Journal:  Br J Pharmacol Chemother       Date:  1967-08
View more
  5 in total

1.  Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.

Authors:  M Barann; M Göthert; K Fink; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

2.  The action of volatile anaesthetics on stimulus-secretion coupling in bovine adrenal chromaffin cells.

Authors:  G Pocock; C D Richards
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

3.  The effects of inhalation anesthetics on calcium-stimulated exocytosis in a natural membrane model system.

Authors:  G Lederhaas; R E Hinkley
Journal:  Cell Biol Toxicol       Date:  1988-06       Impact factor: 6.691

4.  Blockade of adrenal catecholamine release by chlordimeform and its metabolites.

Authors:  A Emran; N M Shanbaky; J L Borowitz
Journal:  Bull Environ Contam Toxicol       Date:  1980-08       Impact factor: 2.151

5.  Inhibitory effects of propofol on catecholamine secretion and uptake in cultured bovine adrenal medullary cells.

Authors:  K Minami; N Yanagihara; K Segawa; M Tsutsui; A Shigematsu; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.